Muralidharan Jagadeesan, MD
Nephrology · Augusta, GANPI 1073623302
Payments from drug & device makers
Across 41 payments — averaging $183.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$7K
- AstraZeneca$212
- Medtronic$135
- Shionogi Inc$69
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$63
- Intercept Pharmaceuticals, Inc.$45
- plus $123 from 4 others
What the payments were for
- Consulting fees$6,32584%
- Food & beverage$1,21516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 22 | $6,893 |
| AstraZeneca(2 entities) | 5 | $212 |
| Medtronic | 2 | $135 |
| Shionogi Inc | 3 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $63 |
| Intercept Pharmaceuticals, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Astellas Pharma US Inc | 1 | $30 |
| Johnson & Johnson | 1 | $28 |
| Baxter Healthcare | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$6,575
- Sonicision$106
- ULTOMIRIS$106
How this compares
$7,540 in reported general payments places this provider in the 75th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $24,064 |
| EliquisApixaban | 19 | $12,452 |
| Envarsus XrTacrolimus | 17 | $7,003 |
| Mycophenolic AcidMycophenolate Sodium | 13 | $2,473 |
| Cinacalcet Hcl | 22 | $1,936 |
| Nifedipine ErNifedipine | 37 | $1,396 |
| Pantoprazole Sodium | 27 | $763 |
| Rosuvastatin Calcium | 37 | $694 |
| Carvedilol | 32 | $646 |
| Labetalol Hcl | 14 | $525 |
| Pravastatin Sodium | 24 | $443 |
| Tamsulosin Hcl | 28 | $422 |
| Losartan Potassium | 41 | $409 |
| Nebivolol Hcl | 13 | $378 |
| Atorvastatin Calcium | 44 | $373 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Augusta
- Harold HubertAugusta$2.8M
- Barton BrezinaAugusta$1.5M
- Laura MulloyAugusta$891K
- Matthew DiamondAugusta$815K
- Devesh PatelAugusta$279K
- Don WilliamsonAugusta$116K
- Syed BabarAugusta$63K
- James StenardAugusta$13K
- James TumlinLawrenceville$19.8M
- Chinedu NwekeAcworth$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.